Prof. Marias’ group used DSC-MRI perfusion data from four MRI scanners at three different sites, from three different manufacturers, and operating at two different field strengths to predict the IDH gene mutation of gliomas. This evidence concerns the gene IDH2 and central nervous system cancer.